Waldencast plc Class A WALD 深 沪
已收盘 02-06 16:00:00 美东时间
1.80
+0.060
+3.45%
华盛通- 最 高1.84
- 今 开1.84
- 成交量 6.10万股
- 最 低 1.7224
- 昨 收 1.74
- 总市值 2.23亿
- 52周最高 3.5399
- 市盈率 静 --
- 换手率 0.05%
- 52周最低 1.45
- 委 比 40.78%
- 总股本 1.24亿
- 历史最高 12.10
- 量 比 0.53
- 振 幅 6.76%
- 历史最低 1.45
- 每 手 1
- 风险率 0.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Waldencast's Obagi Medical Launches Two New Lip Therapy Products, AHA + PHA Smoothing Micro‑Peel And Soothe & Protect Lip Treatment SPF 30, As Targeted Treatment Protocol
Obagi Medical ("Obagi"), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), continues its commitment to advanced
02-03 22:44
Waldencast's Obagi Names Platinum Dermatology Partners As Launch Partner For ALOHA Hyaluronic Acid Program
Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), today announced Platinum Dermatology Partners as the
01-26 21:27
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
2025-11-26 10:07
Canaccord Genuity Maintains Buy on Waldencast, Lowers Price Target to $4
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and lowers the price target from $5 to $4.
2025-11-26 01:51
Waldencast H1 Adj. EPS $(0.16) Misses $(0.07) Estimate, Sales $132.274M Beat $67.692M Estimate
Waldencast (NASDAQ:WALD) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.07) by 122.22 percent. This is a 77.78 percent decrease over losses of $(0.09) per share from the
2025-11-25 06:41
Waldencast shares are trading lower. The company reported Q2 financial results.
Waldencast shares are trading lower. The company reported Q2 financial results.
2025-11-24 22:13
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining ar...
2025-11-24 21:08
Waldencast Plc Sells Its Rights To The "Obagi" Trademark In Japan To Rohto Pharmaceutical For $82.5M
Waldencast plc, (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that it had sold its rights to the "Obagi" trademark in Japan to Rohto Pharmaceutical Co.,
2025-11-15 06:09
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
Obagi Medical introduces Nu-Cil® BioStim™ Scalp Serum, a next-generation product designed to promote fuller, denser hair. Clinically proven to reduce dry, fallen hair by 74% in three months, the serum contains Biotin, Amino Acids, Peptides, and 18 essential Nutrients, B Vitamins, and Phytoactives. It addresses hair loss concerns and enhances overall hair vitality. Priced at $125, it's available on Obagi.com.
2025-10-08 12:00
Waldencast Says FDA Approves Obagi Saypha MagIQ Injectable Hyaluronic Acid Gel
Waldencast plc (NASDAQ:WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has approved Obagi® saypha® MagIQ™ injectable
2025-09-10 18:50
